Advisor Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$6.42M Buy
93,232
+9,474
+11% +$646K 0.04% 340
2019
Q3
$6.16M Buy
83,758
+1,975
+2% +$143K 0.05% 349
2019
Q2
$5.86M Buy
81,783
+943
+1% +$66.9K 0.05% 340
2019
Q1
$5.54M Buy
80,840
+657
+0.8% +$42.4K 0.05% 349
2018
Q4
$4.77M Buy
80,183
+7,395
+10% +$463K 0.05% 322
2018
Q3
$4.87M Buy
72,788
+5,032
+7% +$335K 0.05% 332
2018
Q2
$4.39M Sell
67,756
-278
-0.4% -$18.2K 0.06% 283
2018
Q1
$4.88M Sell
68,034
-9,318
-12% -$671K 0.07% 255
2017
Q4
$5.84M Buy
77,352
+15,212
+24% +$1.11M 0.08% 227
2017
Q3
$4.53M Buy
62,140
+3,848
+7% +$277K 0.07% 252
2017
Q2
$4.32M Buy
58,292
+8,626
+17% +$640K 0.08% 249
2017
Q1
$3.64M Buy
49,666
+5,472
+12% +$383K 0.07% 278
2016
Q4
$2.89M Sell
44,194
-376
-0.8% -$25.8K 0.07% 307
2016
Q3
$3.31M Sell
44,570
-375
-0.8% -$27.7K 0.08% 275
2016
Q2
$3.29M Buy
+44,945
New +$3.2M 0.09% 255

Other funds holding CL

Advisor Group's CL Position: Q4 2019 in Review

Advisor Group increased its Colgate-Palmolive (CL) stake by 11% in Q4 2019, buying an estimated $646K and bringing the position to 93,232 shares worth $6.42M. The position accounts for 0.04% of the portfolio, ranked #340.

Advisor Group first reported a position in CL in Q2 2016 and has held it in 15 quarters since. 1,510 funds tracked by Wall St. Rank hold CL as of Q4 2019.

  • Advisor Group held 93,232 shares of Colgate-Palmolive worth $6.42M as of Q4 2019.
  • Advisor Group bought 9,474 Colgate-Palmolive shares in Q4 2019, an estimated $646K.
  • Colgate-Palmolive made up 0.04% of Advisor Group's portfolio in Q4 2019, its #340 holding.
  • Advisor Group first reported a position in Colgate-Palmolive in Q2 2016 and has held it in 15 quarters since.
  • 1,510 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.